Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v6-EN Version v1-EN
Language English English
Date Updated 2020-03-12 2020-01-03
Drug Identification Number 02413604 02413604
Brand name CARBAMAZEPINE CR CARBAMAZEPINE CR
Common or Proper name CARBAMAZEPINE CR CARBAMAZEPINE CR
Company Name PRO DOC LIMITEE PRO DOC LIMITEE
Ingredients CARBAMAZEPINE CARBAMAZEPINE
Strength(s) 400MG 400MG
Dosage form(s) TABLET (EXTENDED-RELEASE) TABLET (EXTENDED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100 100
ATC code N03AF N03AF
ATC description ANTIEPILEPTICS ANTIEPILEPTICS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date 2020-02-12 2020-02-12
Actual start date
Estimated end date Unknown
Actual end date 2020-03-11
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement
Health Canada comments